Login

Ask AI

Companies $ODTX

$19.50 +$0.20 (1.04%) Close

$ODTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Odyssey Therapeutics Inc

Financial Snapshot

Last updated: 10/27/2026

Size

Revenue: N/A
Net Income: N/A

Growth 2025

Revenue Growth
EPS Growth

Profitability

Gross Margin: N/A
Operating Margin: N/A
Net Income Margin: N/A

Cash flow

Free Cash Flow: N/A

Balance sheet 2026 Q2

Cash
Debt to Equity

Valuation Today

Market Cap: $927.53M
P/E: N/A

Company Facts

Industry: Biological Products, (no Diagnostic Substances)

Loading...

Comments